Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Part of paid clinical trials in Mobile, Alabama.
- Sponsor
- pH-D Feminine Health LLC
- Study ID
- NCT07109869
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Vulvovaginal Candidiases
- Vulvovaginal Candidiasis (VVC)
- Vulvovaginal Candidiasis, Genital
Eligibility Criteria
- Sex
- FEMALE
- Age
- 12 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Boric acid — DRUGBoric acid vaginal inserts consisting of 600 mg boric acid drug substance filled into white, opaque hypromellose capsules with no additional excipients included in the formulation. Each vaginal insert is sealed into a clear blister cavity.
- Placebo — OTHERPlacebo vaginal inserts containing anhydrous lactose and 1% magnesium stearate are also manufactured and filled into white, opaque hypromellose capsules. Packaged in clear blisters.
Study Details
This is a Phase 3 clinical study to evaluate the efficacy, safety, and tolerability of boric acid 600 mg vaginal inserts in patients with VVC.
Key Dates
- Start date
- Aug 8, 2025
- Status verified
- Jun 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 400 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 14 days 600 mg boric acid insertsAll patients will self-administer 600 mg boric acid vaginal inserts once daily for 14 days.
- Experimental: 7 days 600 mg boric acid inserts followed by 7 days placebo insertsAll patients will self-administer 600 mg boric acid vaginal inserts once daily for first 7 days and placebo vaginal inserts for following 7 days.
- Placebo Comparator: 14 days placebo insertsAll patients will self-administer placebo vaginal inserts once daily for 14 days.
Primary Outcome Measure
Proportion of patients with the absence of all signs and symptoms of vulvovaginal candidiasis [ Time Frame: 28 days (+ 2 days) ]
Central Contacts
- Clinical Trial Manager513-709-4442
Locations (27)
Find similar trials in Mobile, AL
By research site
Related Studies
- Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)Recruiting · Coologics, Inc · Jacksonville, Florida